Delivery Order SPE2DB20D2002-SPE2DB25FL65M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $65,022.93 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract awarded on August 27, 2025, with a completion date of September 18, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,128.44 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on June 12, 2025, with an ultimate completion date of July 7, 2025, represents a non-competitive set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 8, 2025, with a completion date of August 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents totaling $6,192.66 under a firm fixed price contract type. This award, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,096.33 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under DLA's pharmaceutical procurement framework. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance of this delivery order will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL65MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,846.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's comprehensive DLA Troop Support Medical IDC (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's IDC vehicle enables it to supply pharmaceutical products, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This Varivax delivery order represents a routine fulfillment of the company's obligations under the broader pharmaceutical prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/11/25 |